EVELO BIOSCIENCES INC vs. NVIDIA Corporation
EVELO BIOSCIENCES INC and NVIDIA Corporation are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| EVLO | NVDA | |
|---|---|---|
| Market Cap | — | $5.27 trillion |
| Revenue (TTM) | — | $302.97 billion |
| Net Income (TTM) | $-82,349,000 | $192.88 billion |
NVDA leads on 2 of 2 size & scale factors.
Valuation
| EVLO | NVDA | |
|---|---|---|
| P/E Ratio | 0.00 | 27.60 |
| Price / Book | — | 23.02 |
| Price / Sales | — | 17.40 |
EVLO leads on 1 of 1 valuation factors.
Profitability
| EVLO | NVDA | |
|---|---|---|
| Net Margin | — | 63.66% |
| Return on Equity | 308.34% | 84.23% |
EVLO leads on 1 of 1 profitability factors.
Dividend
| EVLO | NVDA | |
|---|---|---|
| Dividend Yield | — | 0.46% |
| Payout Ratio | — | 12.64 |
EVLO and NVDA split the dividend factors evenly.
Risk & Sentiment
| EVLO | NVDA | |
|---|---|---|
| Short Interest | — | 0.07% |
EVLO and NVDA split the risk & sentiment factors evenly.
Dig deeper: EVLO overview, EVLO financials, NVDA overview, NVDA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.